A new word for a new approach
Most scientists aren’t in the business of creating new words. Especially chemists and biologists, who stick to a vernacular centered on proteins, molecules and genomes.
But Anil Vasudevan isn’t your typical scientist, and neither are the people on his team within AbbVie’s discovery science group.
Not only have they coined a new term – degradomers – they’re leading the charge to explore how this approach to degrading proteins could eventually help patients with debilitating diseases like rare cancers, immunological conditions and even Parkinson’s and Alzheimer’s diseases.